Abstract |
|
Authors | Karoly Szepeshazi, Andrew V Schally, Andrea Treszl, Stephan Seitz, Gabor Halmos |
Journal | Anti-cancer drugs
(Anticancer Drugs)
Vol. 19
Issue 4
Pg. 349-58
(Apr 2008)
ISSN: 0959-4973 [Print] England |
PMID | 18454045
(Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- AN 215
- AN 238
- Antineoplastic Agents
- Pyrroles
- Receptors, Bombesin
- Receptors, LHRH
- Receptors, Somatostatin
- AN 204
- AN 207
- Gonadotropin-Releasing Hormone
- Doxorubicin
- Bombesin
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology, therapeutic use)
- Antineoplastic Combined Chemotherapy Protocols
(pharmacology, therapeutic use)
- Apoptosis
- Bombesin
(administration & dosage, analogs & derivatives, pharmacology)
- Carcinoma, Hepatocellular
(drug therapy, metabolism, pathology)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Doxorubicin
(administration & dosage, analogs & derivatives, pharmacology)
- Gonadotropin-Releasing Hormone
(administration & dosage, analogs & derivatives, pharmacology)
- Humans
- Immunohistochemistry
- Liver Neoplasms
(drug therapy, metabolism, pathology)
- Mice
- Mice, Nude
- Neoplasm Transplantation
- Pyrroles
(administration & dosage, pharmacology)
- Radioligand Assay
- Receptors, Bombesin
(metabolism)
- Receptors, LHRH
(metabolism)
- Receptors, Somatostatin
(metabolism)
- Transplantation, Heterologous
|